Abstract: A stabilized dihydrolipoic acid (DHLA) compound is provided. The stabilized DHLA is derived from a microbiological culture media including at least one live probiotic organism, R-lipoic acid and at least one nutritive agent. The stabilized DHLA may be prepared by dispersing the microbiological media in distilled water to form a broth, incubating the broth at a predetermined temperature for a select period of time to induce probiotic activity, adding organic ethanol to the broth to halt the probiotic activity, and separating the derived stabilized DHLA from the broth.
Abstract: The present invention provides an effective, all-natural, non-toxic, non-hormonal composition consisting of vitamin D3, vitamin E, selenium, green tea extract, saw palmetto berry extract, isoflavanoids, and lycopene for prostate health. The invention provides compositions and methods to prevent, alleviate, and/or treat symptoms associated with prostate conditions and diseases. The prostate health composition may be used to supplement medical treatment such as radiation therapy, chemotherapy, and hormone therapy.
Abstract: The invention relates to a process for the solid oral pharmaceutical formulation of a pharmaceutically active ingredient such as levetiracetam, comprising a wet granulation of the pharmaceutically active ingredient and simultaneous fluid bed drying such that, as the pharmaceutical blend granulates it is simultaneously dried thus preventing it from becoming a paste. The invention therein thus provides a novel formulation preparation process characterized by a “combined” Granulation and Fluid Bed Drying process step.
Abstract: Nutritional compositions are provided containing at least one PPAR agonist, at least one PGC-1alpha agonist, and at least one creatine derivative. Methods of promoting anabolism and improving or enhancing physical performance using the compositions are provided. The compositions and methods can be combined with physical training or exercise.
Type:
Grant
Filed:
November 9, 2010
Date of Patent:
May 8, 2012
Assignee:
Bio-Engineered Supplements & Nutrition, Inc.
Abstract: The present invention relates to novel compositions uniquely comprising combinations of different grades and/or type of epoxy resins and phosphoric acid into stable, water dispersion, epoxy phosphate ester copolymers. Aqueous thermosetting coating compositions, based on the novel epoxy phosphate ester resins, have the ability to reduce the requirements of curing temperature and time. The resultant coating films have superior protective properties, film properties, and wider applications than the conventional epoxy phosphate ester resins.
Type:
Grant
Filed:
February 19, 2008
Date of Patent:
April 3, 2012
Inventors:
William V. Fenn, Richard A. Elsner, Jr., Lei Zhao
Abstract: A plant grown from seeds derived from a new interhybrid of three plants of the Momordica genus has been cultivated. The new plant hybrid has a faster growth rate than the parent species. Parts of the new interhybrid plant which, when ingested by an individual, have blood glucose and/or insulin regulating properties. Foods and/or beverages containing parts or extracts of the new interhybrid plant and which to promote weight control or loss and/or blood glucose regulation are also disclosed.
Type:
Grant
Filed:
September 15, 2008
Date of Patent:
December 6, 2011
Assignee:
Nutritional Health Institute Laboratories, LLC
Abstract: An insulator member includes a set of passages (2) (4) which, without intercrossing, extend through the main body (1a) of the insulator member. The set of passages (2) (4) includes an insulating passage (2) structurally arranged to be engaged by filiform elements (10) and an elongated anchor passage (4) structurally arranged to be engaged by the hook portion (21) of the stretcher device (20). Since the passages (2) (4) do not intercross, the separating portion (1d) prevents the stretched filiform elements from being subject to compression upon stretching of the stretching device.
Type:
Grant
Filed:
June 17, 2009
Date of Patent:
November 22, 2011
Inventors:
Eduardo Roberto Fernandez, Cesar Hugo Olivera
Abstract: A non-aqueous cleansing formulation having cleansing, moisturizing and/or exfoliating properties includes an oil phase and a natural surfactant derived from legumes and/or grains. The oil phase can include an oil component and a thickening agent. The natural surfactant can be in the form of a particulate flour product derived from Vigna radiata, Vigna mungo, Glycine max, Cicer aerientinum, Vigna unguicalata, Pisum sativum, Phaseolus vulgaris, or combinations thereof, which is dispersed in the oil phase. The flour product suitably includes a high protein flour to emulsify the oil phase and provide improved cleansing action. Such non-aqueous cleansing formulation can be used as skin care products, hand cleansers, hair cleaners or general use cleansers. Advantageously, the cleansing formulations are free of synthetic soaps and/or synthetic surfactants.
Abstract: An antigen composition for stimulating an immune response in an inoculated avian species to at least one intestinal pathogenic organism includes seven field strains of E. coli, Pseudomona aeruginosa, Aerobacter aerogenes, Salmonella enteritidis, Salmonella typhimurium, Salmonella agona, and Salmonella Kentucky. The antigen composition can be used alone or in combination with a Marek's Disease vaccine to reduce shedding of E. coli and/or Salmonella bacteria.
Type:
Grant
Filed:
June 4, 2010
Date of Patent:
August 2, 2011
Assignee:
Nutrional Health Institute Laboratories, LLC
Abstract: The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of at least one organic base, as well as compositions and uses thereof. The compounds of the invention show a long lasting stability as well as a peculiarly high water-solubility.
Type:
Grant
Filed:
February 20, 2008
Date of Patent:
May 24, 2011
Assignee:
GNOSIS S.p.A.
Inventors:
Ermanno Valoti, Davide Bianchi, Marco Valetti
Abstract: An antigen composition for stimulating an immune response in an inoculated avian species to at least one intestinal pathogenic organism includes naturally-occurring wild Salmonella enterica subspecies in O-serogroups B, C3 and D. Subspecies in O-serogroup B can include Salmonella typhimurium and/or Salmonella agona. Subspecies in O-serogroup C3 can include Salmonella Kentucky. Subspecies in O-serogroup D can include Salmonella enteritidis. The antigen composition can be used alone or in combination with a Marek's Disease vaccine to reduce shedding of E. coli and/or Salmonella bacteria.
Type:
Grant
Filed:
February 4, 2008
Date of Patent:
May 3, 2011
Assignee:
Nutritional Health Institute Laboratories, LLC
Abstract: A dietary supplement composition having an ORAC value in excess of at least about 2,500 and which can be readily consumed in a small quantity is provided for supplementing an individual's daily intake. The dietary supplement composition suitably includes organic and/or vegan ingredients and can be consumed in quantities of as little as about 1 tablespoon to provide an amount of antioxidants equivalent to at least the minimum recommended daily intake of five to nine servings of fruits and/or vegetables.
Abstract: The invention relates to self adhesive material (SAM) using water soluble film incorporated with surfactants and/or fillers as a protective layer, eliminating the release liner (backing liner). The water soluble film incorporated with surfactants and/or fillers, used as a protective liner, provides easy breakage, faster dissolution as well as easy application to an object. The invention also relates to a process for the preparation of self adhesive material (SAM) without release liner and an apparatus and a method for applying the self adhesive material (SAM) on an object.
Abstract: This invention relates to a process for the synthesis and method of use of an effective amount of a creatine heterocyclic acid salt for the regulation athletic function in humans.
Type:
Grant
Filed:
January 8, 2007
Date of Patent:
December 13, 2011
Assignee:
Bio-Engineered Supplements & Nutrition, Inc.